2011
DOI: 10.1016/j.fertnstert.2011.03.022
|View full text |Cite
|
Sign up to set email alerts
|

Hormone-induced delayed ovulation affects early embryonic development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(21 citation statements)
references
References 28 publications
(32 reference statements)
1
19
1
Order By: Relevance
“…For example, supraphysiologic E 2 levels have been shown to have a toxic effect on the developing embryo in mice, leading to impairment in embryonic adhesion and implantation potential [19][20][21]. Elevated estrogen levels also impair the expression of implantation-associated genes in mice, leading to aberrant placentation [22].…”
Section: Discussionmentioning
confidence: 99%
“…For example, supraphysiologic E 2 levels have been shown to have a toxic effect on the developing embryo in mice, leading to impairment in embryonic adhesion and implantation potential [19][20][21]. Elevated estrogen levels also impair the expression of implantation-associated genes in mice, leading to aberrant placentation [22].…”
Section: Discussionmentioning
confidence: 99%
“…To achieve prolonged follicle growth and oogenesis in vivo , ovulation was delayed in superovulated 4-6 week old C57Bl/6J female mice by application of the GnRH antagonist cetrorelix (Cetrotide, Merck-Serono), as described previously [2,11]. In short, mice were stimulated by intraperitoneal injection of 10 IU pregnant mare serum gonadotropin (PMSG; Intergonan, MSD) to induce follicle growth.…”
Section: Methodsmentioning
confidence: 99%
“…Even though preovulatory aging is known to reduce oocyte quality and can cause developmental defects in the embryo in many different animal models, such as frogs, fish, urodeles, guinea pigs and rats [1], little is known about the underlying molecular mechanisms. Recently, an in vivo mouse model was established to investigate preovulatory aging in more detail [2]. In this model, ovulation was postponed by application of the gonadotropin releasing hormone (GnRH) antagonist cetrorelix, resulting in decreased embryo weight and increased embryo resorption [2].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…E2 (250 ng dissolved in 0.1 mL of peanut oil; Sigma-Aldrich Co., St Louis, MO) and/or P (2 mg dissolved in 0.1 mL of peanut oil; Sigma-Aldrich Co.) were administered subcutaneously to some of the OVX mice, at 1,000 h for five consecutive days [9,10]. Three days before sampling, the GnRH antagonist cetrorelix (10 µg in 0.2 mL saline/daily, S.C.; Cetrotide, Merck KGaA, Darmstadt, Germany) was administered subcutaneously to some of the OVX mice, at 1,000 h for three consecutive days [11]. Six days after ovariectomy, the mice were decapitated between 1,000 and 1,200 h, and their pituitary glands and uteri were collected for RNA extraction and wet weight measurements, respectively.…”
Section: Ovariectomy and Hormonal Replacementmentioning
confidence: 99%